A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem.
about
Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled studyUK guidelines for the management of acute pancreatitisProbiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]Pro/con clinical debate: antibiotics are important in the management of patients with pancreatitis with evidence of pancreatic necrosisPresent and future of prophylactic antibiotics for severe acute pancreatitisRole of cytokines and their inhibitors in acute pancreatitisInfluence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis.The role of infection in acute pancreatitisBehavior of antibiotics during human necrotizing pancreatitis.Consensus of primary care in acute pancreatitis in Japan.Luminal lactate in acute pancreatitis--validation and relation to disease severity.Management of necrotizing pancreatitis.The impact of hospital-acquired infection on outcome in acute pancreatitis.Antimicrobial activity of human pancreatic juice and its interaction with antibiotics.A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis.Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis.Continuous regional arterial infusion and laparotomic decompression for severe acute pancreatitis with abdominal compartment syndrome.Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study.Update on pathogenesis and clinical management of acute pancreatitis.II. The Endocrine and Pancreatic Unit at the University of Verona, Italy.Efficacy of antibiotic penetration into pancreatic necrosis.Hemoconcentration is a poor predictor of severity in acute pancreatitisQuestions about the use of antibiotics in acute pancreatitis.Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics.An audit of fatal acute pancreatitis.Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis.Pharmacological approach to acute pancreatitis.Failure to follow evidence-based best practice guidelines in the treatment of severe acute pancreatitis.Effects of Chai-Qin-Cheng-Qi Decoction on cefotaxime in rats with acute necrotizing pancreatitis.JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis.Nutrition, inflammation, and acute pancreatitis.Fluconazole penetration into the pancreas.Interleukin-6: An Early Predictive Marker for Severity of Acute PancreatitisThe role of the intestine in the pathophysiology and management of severe acute pancreatitis.Trends in fungal colonization of pancreatic necrosis in patients undergoing necrosectomy for acute pancreatitis.Acute pancreatitis at the beginning of the 21st century: the state of the art.Surgery for pancreatic necrosis: "whom, when and what".Surgical Treatment of Necrotizing Pancreatitis.Antibiotic-Induced Pathobiont Dissemination Accelerates Mortality in Severe Experimental Pancreatitis.Acute necrotizing pancreatitis: treatment strategy according to the status of infection.
P2860
Q24681368-9C14A447-459A-4D08-BA9C-3D5AB060FDD2Q24685861-4197C35E-25F0-4F3B-B793-EFC2C107DB07Q24791550-22F5CCCB-3073-4045-92AF-47C3A2BA1BDFQ24795769-3E34106F-B80B-4718-83BE-0E2C03B098A1Q27003317-CC0AD25E-BC44-4F94-9AD5-7D8F00BF0A37Q33617636-DCD738C1-B85A-45BA-AF96-B58CDFC9EDF1Q33618014-3487861F-A528-4E4F-9E04-4D1797BB9C47Q33686178-18F4FC53-7033-4AA3-9FD7-5145B5CE1DCBQ33753205-F217E50C-4ACA-4BA7-87E6-35DE499A2FCEQ33868047-139B2E5C-48DD-4957-9804-E07ACCE58122Q34251532-742C1B56-4C8D-469E-993B-4FE4E59506B2Q34512097-86898207-274C-4A78-B763-915285BDBBD8Q34794469-2483735D-687A-43EF-BE32-F341C56F7249Q35126768-BD05CCF6-EA3C-4E66-8FE3-E556B5257E7BQ35355748-04A0EDDC-D738-417C-AF4D-62FB7B1F3FC3Q35358768-91FB8652-9803-459B-8FA5-30BFA00518C5Q35606939-F5BC7528-3712-45A5-925A-F388C4F53F59Q35654012-F57F19DE-1594-4983-9347-9F5BAD1522FCQ36057055-E7C8EB48-0E43-4524-9484-A7968988ACE2Q36063135-29A0AFE1-977F-467E-A313-615265212687Q36253169-AA131895-A8F5-4B17-A888-712ABF9F7292Q36474514-EB9043F7-2D0F-4FEB-8324-466823A651C3Q36527025-9D22486F-CF14-4B31-926A-D4076D5C0C14Q36588446-8AE837A8-5915-492C-93AD-953C0573C3C4Q36680229-3ED70A8E-B5F5-4D39-9713-BC13765C6A5FQ37106110-D19520B4-C58D-4E23-80B4-A95BE093931DQ37169329-D275DC4B-A2DD-4C8E-BB54-86570D0E99E7Q37216673-8E470F53-4F1B-4BF1-9208-7C3F9DDEF557Q37353872-EDDB7A89-F868-4913-9675-0613C287F3B6Q37426008-48EFA72D-9D0D-4E85-BD61-D000059C38E4Q38184562-AF2E7932-9EAC-4042-8981-1445D709890BQ39475094-429EF636-9E83-4250-9EC2-904D477DCE81Q41196827-88D49CBD-5091-494A-BCCC-0E572BC7E1B5Q42571548-DE910AD7-3C48-4ACD-8942-4949A913019FQ42576527-ACBA2D63-CAA0-4C5B-86B6-3A3EE553F7E1Q43088026-8EFC0A9C-B429-4F9B-AAD0-39106DFD4E8CQ43248605-5E5A5632-4BD7-49F0-BA17-C81083DE04F6Q45782078-78A9984A-8112-493F-BCBE-75CB1F07B4F9Q49190229-8D996025-1F33-4252-A7C1-9EDA26E551D5Q50185728-CA481256-029B-468C-AA53-299646759EFD
P2860
A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem.
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
A randomized multicenter clini ...... ng pancreatitis with imipenem.
@ast
A randomized multicenter clini ...... ng pancreatitis with imipenem.
@en
A randomized multicenter clini ...... ng pancreatitis with imipenem.
@nl
type
label
A randomized multicenter clini ...... ng pancreatitis with imipenem.
@ast
A randomized multicenter clini ...... ng pancreatitis with imipenem.
@en
A randomized multicenter clini ...... ng pancreatitis with imipenem.
@nl
prefLabel
A randomized multicenter clini ...... ng pancreatitis with imipenem.
@ast
A randomized multicenter clini ...... ng pancreatitis with imipenem.
@en
A randomized multicenter clini ...... ng pancreatitis with imipenem.
@nl
P2093
P1476
A randomized multicenter clini ...... ing pancreatitis with imipenem
@en
P2093
Campedelli A
Pederzoli P
Vesentini S
P304
P577
1993-05-01T00:00:00Z